24P Is molecular characterization useful for targeted...

Annals of Oncology 2020 / 10 Vol. 31

24P Is molecular characterization useful for targeted therapy orientation in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) included in early phase clinical trials?

Michot, J-M., Camara-Clayette, V., Quivoron, C., Danu, A., Lazarovici, J., Ghez, D., Rossignol, J., Baldini, C., Martin Romano, P., Sarkozy, C., Varga, A., Cotteret, S., Dartigues, P., Massard, C., Ri
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.2183
Date:
October, 2020
File:
PDF, 83 KB
2020
Conversion to is in progress
Conversion to is failed